Global unlocking may not be good news for pharma firms; Q1’s strong revenue growth may not sustain

Global unlocking may not be good news for pharma firms; Q1’s strong revenue growth may not sustain

While Indian pharmaceutical companies posted good performance in Q1FY21, they are unlikely to sustain good margins with the reopening of economies across the globe.
Check the source here –Source, Financial Express.

Leave your comment
Comment
Name
Email
Change Language